Related Experiment Video
Updated: Aug 23, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
Molecular biology of primary hyperparathyroidism
Robert L Ferris1, Alfred A Simental
1Department of Otolaryngology, University of Pittsburgh Eye and Ear Institute, 203 Lothrop Street, Suite 500, Pittsburgh, PA 15213, USA. ferrisrl@upmc.edu
Abstract:
As molecular biology and genetic mapping receive wider application to human disease, genetic alterations have been identified with increased frequency in some patients with primary hyperparathyroidism(HPT). These alterations have been found in molecules related to cellular signaling and growth (RET proto-oncogene)and in tumor suppressors that control cell cycle progression and gene transcription (cyclin D1 and the MEN1 gene product. Although primary HPT can usually be treated surgically without knowledge of which specific genetic alteration has occurred, this information may assist clinicians in identifying which patients will go on to develop multiglandular or recurrent disease. In addition,such an approach would facilitate more appropriate postoperative surveillance, as well as counseling and screening of family members who may be at high risk for HPT.
Insights
Genetic alterations in primary hyperparathyroidism (HPT) are increasingly found. Identifying these genetic changes aids in predicting multiglandular or recurrent disease and guides patient management.
Area of Science:
- Endocrinology
- Human Genetics
- Molecular Biology
Background:
- Primary hyperparathyroidism (HPT) is a condition where the parathyroid glands produce too much parathyroid hormone.
- Genetic alterations are increasingly identified in patients with HPT.
- These alterations involve genes related to cell signaling, growth, and tumor suppression.
Purpose of the Study:
- To explore the significance of genetic alterations in primary hyperparathyroidism.
- To determine if genetic information can predict disease progression and recurrence.
- To enhance clinical management and family screening for HPT.
Main Methods:
- Review of genetic alterations identified in primary hyperparathyroidism patients.
- Analysis of genes such as RET proto-oncogene, cyclin D1, and MEN1.
- Correlation of genetic findings with clinical outcomes like multiglandular or recurrent disease.
Main Results:
- Specific genetic alterations have been identified in patients with HPT.
- These alterations are linked to key cellular processes including signaling, growth, cell cycle, and gene transcription.
- Knowledge of these alterations can inform prognosis.
Conclusions:
- Identifying genetic alterations in primary hyperparathyroidism can help predict multiglandular or recurrent disease.
- This information is valuable for tailoring postoperative surveillance.
- Genetic insights facilitate appropriate counseling and screening for at-risk family members.
Related Concept Videos
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis
Bone Remodeling
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...

